【肺癌】「HistoTME」: 預測「非小細胞肺癌」患者對免疫檢查點抑制劑反應的弱監督深度學習

 【肺癌】「HistoTME」: 預測「非小細胞肺癌」患者對免疫檢查點抑制劑反應的弱監督深度學習

 文章出處  

Docwirenews 

 

 原文標題  

Researchers Use Deep Learning Approach to Characterize Tumor Microenvironment, Predict Immune Checkpoint Inhibitor Outcomes in NSCLC 

 

 文章序號  

6633 

 

智醫科學－AI醫療技術、應用與市場動態

Copyright ©2024 智醫科學 MEDai.tw All rights reserved.

The content of this site is intended for healthcare and medical professionals.